---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-018467"
form_type: "8-K"
ticker: "MGRX"
cik: "0001938046"
company_name: "MANGOCEUTICALS, INC."
filed_at: "2025-07-10T23:59:59+00:00"
generated_at: "2026-05-18T08:47:46.017302+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Mangoceuticals subsidiary designates 1M shares of 6% Series B Convertible Preferred

## Summary
- Series B Preferred has $10 stated value, 6% cumulative dividend payable quarterly.
- Conversion price fixed at $1.50 per common share, with 4.999% beneficial ownership cap.
- Liquidation preference of $12.50 per share plus accrued dividends; company can redeem at $12.50 after 3 years.
- No voting rights except protective provisions requiring majority approval for adverse changes.
- Issued by wholly-owned subsidiary Mango & Peaches Corp.; no immediate proceeds or issuance disclosed.

## SEC filing metadata
- accession: 0001641172-25-018467
- form_type: 8-K
- ticker: MGRX
- cik: 0001938046
- company_name: MANGOCEUTICALS, INC.
- filed_at: 2025-07-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1938046/000164117225018467/0001641172-25-018467-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1938046/000164117225018467/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-018467
- JSON: https://secwatch.observer/filing/0001641172-25-018467.json
- Plain text: https://secwatch.observer/filing/0001641172-25-018467.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.